Drugs and drug targets for the treatment of HPV-positive cervical cancer
{{output}}
Cervical cancer is primarily driven by persistent infection with high-risk human papillomavirus (HPV) strains and remains a significant global health challenge, particularly in low- and middle-income countries where late-stage diagnoses is common. While vaccin... ...